Eyeing a presence in the lucrative and growing Russian market, Ahmedabad-based Cadila Pharmaceuticals is looking at investing up to $150 million to build a pharmaceutical manufacturing plant in the Astrakhan Region. Cadila Managing Director Rajiv ... EHealth Magazine, 1 month ago
Microbix Biosystems Inc. (MBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new company profile report - TransWorldNews, 5 days ago
Drug pricing regime comes into effect; pharma stocks mixed - Moneycontrol.com, 1 week ago
3 images for "cadila pharmaceutical"
Gujarat based pharmaceutical company informed BSE that its board and the Board of Directors of ZAHL, LHL and ZPL reached the conclusion at their respective meetings held on April 22. has approved the merger of (ZAHL), (LHL) and Zydus Pharmaceuticals ...India Infoline, 1 month ago Cadila Healthcare approves merger of companies Equity Bulls, 4 weeks ago Cadila Healthcare: Outcome of board meeting Money Control, 1 month ago Cadila Healthcare to merge certain subsidiaries with itself Smart Investor, 1 month ago
If the recently notified Drugs (Price Control) Order, 2013 spells good news for patients, it certainly causes worry lines for pharma companies, who say their profitability and margins will be affected in the immediate term. As per the order, prices ...New Indian Express, 3 days ago With DPCO, margins of pharma players may take a hit Sify, 3 days ago Drug prices to get 80% cheaper TruthDive, 4 days ago New drug policy to impact multinational firms more Financial Chronicle, 4 days ago
Cadila Healthcare has declared the first day launch of Zolmitriptan orally disintegrating tablets upon receiving the final approval from the US Food and Drug Administrator (USFDA). The drug is used in the treatment of migraine, has an estimated sale ...Indian-Commodity, 1 week ago Cadila Healthcare in pink of health on launch of Zolmitriptan in US India Infoline, 1 week ago BSE Healthcare index touches new 52-weeks high at 9077.73 PharmaBiz, 1 week ago
Shares of drug makers fell on Monday, after the government notified a new pricing policy designed to cap the prices of a greater number of formulations. The BSE's healthcare index fell 1.8 per cent, against the Sensex's 0.3 per cent fall, as ...Sify, 3 days ago
Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 20 May 13 | 03:34 PM 444.15 -27.3 (-5.79%) NSE 20 May 13 | 03:31 PM 443.60 -27.9 (-5.92%) Shares of pharmaceutical companies are under pressure in noon deals trades and declined ...Smart Investor, 4 days ago New drug policy: Consumers gain, companies to feel the heat Smart Investor, 4 days ago
After a phase of low growth (Nov 2012-March 2013), domestic pharmaceutical market has shown some signs of recovery with 9.7% growth for the month of April 2013 versus 5.6% in March 2013. Most stocks under coverage posted growth in-line with market. Amongst ...Myiris, 4 days ago
With another financial year ending, pharmaceutical companies have seen huge growth in their market capitalisation. The top 10 stocks (by market cap) showed about 40 per cent growth last year. Though some stocks such as Ranbaxy, GSK Pharma and Cadila ...Smart Investor, 1 month ago Pharma cos market cap grows 40% in FY13 Smart Investor, 1 month ago Pharma: All eyes on March 2013 growth rate Smart Investor, 1 month ago Top 50 pharma cos report 22% growth in sales in 9 months of 2012-13: Pharmabiz study PharmaBiz, 2 months ago
Local drug makers are increasingly looking at tapping another off-patent opportunity, that of biosimilars. These can be called the generic version of biologics or drugs that are derived from living organisms or organic substances. Pharma companies ...Smart Investor, 2 weeks ago
Hiring activity up by 14 per cent in March 13 over Feb 13 The pharmaceutical sector is likely to drive the hiring growth in 2013. The sector has emerged as a powerful employer with the hiring activity being up by 14 per cent in March 13 over Feb 13.Express Pharma, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!